Funded Tech Companies
Mnemosyne Pharmaceuticals
Wondering who provided funding to Mnemosyne Pharmaceuticals? Clal Biotechnology Industries, Atlas Venture and Access BridgeGap Ventures joined the equity holders in this innovative biopharmaceutical company.
Company Overview
Company Name
Mnemosyne Pharmaceuticals
Company Status
Private & Independent
Industry
Funding Rounds
Total Funding
Contact Information
Mailing Address
400 Technology Sq. 10th Floor
Cambridge, MA 02139
USA
Cambridge, MA 02139
USA
Phone
Website
Email Address
Company Background Information
Overview
The company is a Providence-based drug discovery venture aiming to develop small molecule therapeutics to treat schizophrenia and other cognitive and neuropsychiatric disorders.
Profile
Social Media
Company News
Facebook
YouTube
Last Transaction
3/31/2015
Financing History
Date
Type
Amount
Management Team
Title
Name
Email & Social
Chief Executive Officer
Vanessa King
Chief Scientific Officer
Tim Piser
Vice President
Robert Volkmann
VP - Operations
David Anderson
Company Investors
- Clal Biotechnology Industries
- Atlas Venture
- Access BridgeGap Ventures
- Slater Technology Fund
Browse more funded tech companies:
Share this article
About Our Venture Capital Database
Our data comes from VentureDeal.com, a market leader in private equity transaction data.
Additional Resources for Entrepreneurs